
TOKYO -- Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage.
The DNA vaccine project is a collaboration between biotech venture AnGes and Takara Bio, which will handle most of the production work.